Contribution of MSH2, MLH1, MSH6 and TGFBR2 germline mutations to colorectal cancer susceptibility and its prevalence.

被引：0
|
作者：
Lagarde, AE
Baumann, E
Danis, L
Stem, HS
机构：
[1] Ottawa Hlth Res Inst, Ottawa, ON, Canada
[2] Univ Ottawa, Dept Surg, Ottawa, ON, Canada
[3] Ottawa Canc Ctr, Ottawa, ON, Canada
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 2002年 / 71卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
363
引用
收藏
页码：234 / 234
页数：1
相关论文
共 50 条
  • [41] MSH2 and MLH1 testing
    Kurzawski, Grzegorz
    Suchy, Janina
    Lubinski, Jan
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2008, 6 (02) : 83 - 83
  • [42] Association of MLH1 and MSH2 promoter polymorphisms and colorectal cancer
    Mrkonjic, Miralem
    Raptis, Stavroula R.
    Pethe, Vaiju
    Knight, Julia
    Monga, Neerav
    Daftary, Darshana
    Younghusband, Ban
    Parfrey, Patrick
    Gallinger, Steve
    Green, Roger
    McLaughlin, John
    Bapat, Bharati
    CANCER RESEARCH, 2006, 66 (08)
  • [43] Cumulative risk of developing colorectal adenomas during colonoscopic surveillance in MLH1, MSH2 or MSH6 mutation carriers
    Broes, M. J. M.
    Duif, V.
    Saksens, N. T. M.
    Visser, N. C. M.
    Woliner, Y.
    Nagtegaal, I. D.
    van Kouwen, M. C. V.
    Nagengast, F. M.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (03) : A82 - A82
  • [44] High-Resolution Melting Analyses for Gene Scanning of APC, MLH1, MSH2, and MSH6 Associated with Hereditary Colorectal Cancer
    Obul, Jurat
    Itoga, Sakae
    Abliz, Maynur
    Sato, Kenichi
    Ishige, Takayuki
    Utsuno, Emi
    Matsushita, Kazuyuki
    Matsubara, Hisahiro
    Nomura, Fumio
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2012, 16 (05) : 406 - 411
  • [45] Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations:: The German hereditary nonpolyposis colorectal cancer consortium
    Plaschke, J
    Engel, C
    Krüger, S
    Holinski-Feder, E
    Pagenstecher, C
    Mangold, E
    Moeslein, G
    Schulmann, K
    Gebert, J
    Doeberitz, MV
    Rüschoff, J
    Loeffler, M
    Schackert, HK
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (22) : 4486 - 4494
  • [46] MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by genomic rearrangements in Hereditary Non-Polyposis Colorectal Cancer.
    Charbonnier, F
    Olschwang, S
    Wang, Q
    Boisson, C
    Martin, C
    Buisine, MP
    Puisieux, A
    Frebourg, T
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 192 - 192
  • [47] Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2)
    Rahner, Nils
    Steinke, Verena
    Schlegelberger, Brigitte
    Olschwang, Sylviane
    Eisinger, Francois
    Hutter, Pierre
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2010, 18 (09) : 1071 - 1071
  • [48] Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2)
    Nils Rahner
    Verena Steinke
    Brigitte Schlegelberger
    Sylviane Olschwang
    François Eisinger
    Pierre Hutter
    European Journal of Human Genetics, 2010, 18 : 1071 - 1071
  • [49] DNA repair proteins MLH1, MSH2, MSH6, and MGMT in 495 gastric and esophageal adenocarcinomas
    Fukuda, E.
    Begnami, M. D.
    Fregnani, J. H.
    Silva, E. M.
    Soares, F. A.
    Coudry, R. A.
    Soares, F. A.
    LABORATORY INVESTIGATION, 2008, 88 : 119A - 119A
  • [50] Additional loss of MSH2 and MSH6 expression in sporadic deficient mismatch repair colorectal cancer due to MLH1 promoter hypermethylation
    Westwood, Alice
    Glover, Amy
    Hutchins, Gordon
    Young, Caroline
    Brockmoeller, Scarlet
    Robinson, Rachel
    Worrilow, Lisa
    Wallace, Dave
    Rankeillor, Kate
    Adlard, Julian
    Quirke, Philip
    West, Nicholas
    JOURNAL OF CLINICAL PATHOLOGY, 2019, 72 (06) : 443 - 447
12345